Skip to main content
NAVCO Pharmaceuticals logo

NAVCO Pharmaceuticals — Investor Relations & Filings

Ticker · NAV ISIN · CA63942R1091 LEI · 8945003WKDH61M8UB963 TSXV Manufacturing
Open in API
Filings indexed 199 across all filing types
Latest filing 2021-10-05 Regulatory Filings
Country CA Canada
Listing TSXV NAV

About NAVCO Pharmaceuticals

https://www.navcopharma.com/

NAVCO Pharmaceuticals is a biotechnology company specializing in the research, development, and commercialization of nanotechnology products and materials. The company utilizes proprietary Computerized Nano-meter Algorithms to create innovative solutions for anti-viral, anti-fungal, and anti-bacterial treatments. NAVCO focuses on developing supplemental and therapeutic consumer health and wellness products. A key offering is the BioActive™ line, which includes non-toxic, non-flammable, and alcohol-free hand cleansers, creams, and surface disinfectants designed to provide extended protection against germs and microorganisms. These nanotechnology products are marketed across various sectors, including medicine and textiles, providing next-generation protection solutions for multiple industries.

Recent filings

Filing Released Lang Actions
52-109FV1 - Certification of annual filings - CFO (E).pdf
Regulatory Filings Classification · 95% confidence The document is a certification statement by the CFO of BMGB Capital Corp. regarding the accuracy and fair presentation of the company's annual filings for the financial year ended June 30, 2021. It references the annual filings including the AIF, annual financial statements, and annual MD&A, but does not contain the actual financial data or detailed report content itself. The document is a formal officer certification under Form 52-109FV1, which is a regulatory compliance filing. According to the Certification Rule, such certifications should be classified as Regulatory Filings (RNS) rather than the actual annual report (10-K) or other financial reports. The document length is short (3104 characters), and it is clearly a certification letter rather than the full report or announcement of a report publication. Therefore, the correct classification is Regulatory Filings (RNS).
2021-10-05 English
52-109FV1 - Certification of annual filings - CEO (E).pdf
Regulatory Filings Classification · 95% confidence The document is a Form 52-109FV1, which is a certification of annual filings by a venture issuer's CEO. It certifies the review and fair presentation of the annual filings, including the annual financial statements and MD&A, for the financial year ended June 30, 2021. The document is primarily an officer certification letter and does not contain actual financial data or the full annual report itself. According to the Certification Rule, such certification documents should be classified as Regulatory Filings (RNS) rather than as the Annual Report (10-K) or other financial reports. The document length is 3091 characters, which is relatively short and consistent with a certification letter rather than a full report.
2021-10-05 English
Annual MD&A - English.pdf
Management Reports Classification · 100% confidence The document is titled 'Management's Discussion and Analysis' (MD&A) for the year ended June 30, 2021, dated October 5, 2021. It contains detailed discussion of the company's financial position, results of operations, liquidity, capital resources, quarterly results, and outlook. It references audited financial statements and IFRS accounting policies, and includes substantive financial data and analysis for the fiscal year. The MD&A is a management report explaining financial results and business trends, which fits the definition of Management Reports (MDA). The document is about 15,000 characters, indicating it is a full report, not a brief announcement or certification. Therefore, the appropriate classification is Management Reports (MDA).
2021-10-05 English
AB form 13-501F1 (class 1 and 3B reporting issuers - participation fee).pdf
Regulatory Filings Classification · 100% confidence The document is titled 'FORM 13-501F1' and is a 'Management Certification' submitted to the Alberta Securities Commission. It includes detailed calculations of market values, capitalization, and participation fees for Class 1 and Class 3B reporting issuers. The content is primarily a certification by an officer (CEO Lucas Birdsall) attesting to the completeness and accuracy of the information provided in the form. There are no financial statements, management discussion, or detailed financial results presented. The document is a regulatory filing form with officer certification rather than a full financial report or announcement. Therefore, it fits best under the 'Regulatory Filings (RNS)' category, which includes officer certifications and miscellaneous regulatory documents that do not fit other categories.
2021-10-05 English
Audited annual financial statements – English.pdf
Audit Report / Information Classification · 100% confidence The document is titled 'INDEPENDENT AUDITOR'S REPORT' and contains detailed audited financial statements for BMGB Capital Corp. for the year ended June 30, 2021. It includes the auditor's opinion, basis for opinion, material uncertainty related to going concern, responsibilities of management and auditors, and detailed financial statements such as statements of financial position, operations, changes in equity, cash flows, and notes to the financial statements. The presence of a full audit report with financial statements and notes indicates this is a standalone audit report rather than a full annual report or other filing. The document length is substantial (15,000 characters), and it contains actual financial data and audit opinion, not just an announcement or certification. Therefore, the appropriate classification is Audit Report / Information (AR). FY 2021
2021-10-05 English
ON form 13-502F1 (class 1 and 3B reporting issuers - participation fee).pdf
Regulatory Filings Classification · 95% confidence The document is a Form 13-502F1 Management Certification submitted to the Ontario Securities Commission. It contains a certification by an officer (CEO Lucas Birdsall) regarding the completeness and accuracy of the information provided in the form. The content includes participation fee calculations under OSC Rule 13-502 Fees, market value data, and fee tables. There are no financial statements or substantive financial data typical of annual or interim reports. The document is primarily a certification and regulatory compliance filing related to participation fees, not a financial report or announcement of a report. Therefore, it fits best under Regulatory Filings (RNS) as it is a regulatory submission and officer certification.
2021-10-05 English

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.